<VariationArchive RecordType="classified" VariationID="14706" VariationName="NC_000019.10:g.(?_7112255)_(7249328_?)del" VariationType="Deletion" Accession="VCV000014706" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2017-01-06" MostRecentSubmission="2017-01-06">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="29745" VariationID="14706">
      <GeneList>
        <Gene Symbol="LOC130063351" FullName="ATAC-STARR-seq lymphoblastoid active region 13874" GeneID="130063351" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="7216755" stop="7216824" display_start="7216755" display_stop="7216824" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="INSR" FullName="insulin receptor" GeneID="3643" HGNC_ID="HGNC:6091" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="7112265" stop="7294414" display_start="7112265" display_stop="7294414" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="7112265" stop="7294010" display_start="7112265" display_stop="7294010" Strand="-" />
          </Location>
          <OMIM>147670</OMIM>
        </Gene>
        <Gene Symbol="LOC129391047" FullName="MPRA-validated peak3314 silencer" GeneID="129391047" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="7113365" stop="7113565" display_start="7113365" display_stop="7113565" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129391048" FullName="MPRA-validated peak3317 silencer" GeneID="129391048" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="7222164" stop="7222364" display_start="7222164" display_stop="7222364" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130063348" FullName="ATAC-STARR-seq lymphoblastoid active region 13870" GeneID="130063348" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="7179195" stop="7179294" display_start="7179195" display_stop="7179294" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130063349" FullName="ATAC-STARR-seq lymphoblastoid active region 13871" GeneID="130063349" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="7192383" stop="7192472" display_start="7192383" display_stop="7192472" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130063350" FullName="ATAC-STARR-seq lymphoblastoid active region 13872" GeneID="130063350" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="7192523" stop="7192612" display_start="7192523" display_stop="7192612" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000019.10:g.(?_7112255)_(7249328_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" innerStart="7112255" innerStop="7249328" display_start="7112255" display_stop="7249328" variantLength="137074" Strand="-" />
      </Location>
      <OtherNameList>
        <Name>INSR, DEL</Name>
        <Name>DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.(?_7112255)_(7249328_?)del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.(?_7112255)_(7249328_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="nssv7487177" DB="dbVar" />
        <XRef ID="nsv1197527" DB="dbVar" />
        <XRef Type="Allelic variant" ID="147670.0028" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">Deletion of entire INSR gene.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000019.10:g.(?_7112255)_(7249328_?)del AND Leprechaunism syndrome" Accession="RCV000015821" Version="29">
        <ClassifiedConditionList TraitSetID="4059">
          <ClassifiedCondition DB="MedGen" ID="C0265344">Leprechaunism syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1993-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1993-09-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-01-06" MostRecentSubmission="2017-01-06">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27896077</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7693131</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="4059" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4966" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Donohue syndrome</ElementValue>
                <XRef ID="MONDO:0009517" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Leprechaunism syndrome</ElementValue>
                <XRef ID="Leprechaunism+syndrome/8731" DB="Genetic Alliance" />
                <XRef ID="111307005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leprechaunism</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">INSR-related severe syndromic insulin resistance comprises a phenotypic spectrum that is a continuum from the severe phenotype Donohue syndrome (DS) (also known as leprechaunism) to the milder phenotype Rabson-Mendenhall syndrome (RMS). DS at the severe end of the spectrum is characterized by severe insulin resistance (hyperinsulinemia with associated fasting hypoglycemia and postprandial hyperglycemia), severe prenatal growth restriction and postnatal growth failure, hypotonia and developmental delay, characteristic facies, and organomegaly involving heart, kidneys, liver, spleen, and ovaries. Death usually occurs before age one year. RMS at the milder end of the spectrum is characterized by severe insulin resistance that, although not as severe as that of DS, is nonetheless accompanied by fluctuations in blood glucose levels, diabetic ketoacidosis, and – in the second decade – microvascular complications. Findings can range from severe growth delay and intellectual disability to normal growth and development. Facial features can be milder than those of DS. Complications of longstanding hyperglycemia are the most common cause of death. While death usually occurs in the second decade, some affected individuals live longer.</Attribute>
                <XRef ID="NBK476444" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">INSR-Related Severe Syndromic Insulin Resistance</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6885" />
                <XRef ID="6885" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29369573</ID>
                <ID Source="BookShelf">NBK476444</ID>
              </Citation>
              <XRef ID="508" DB="Orphanet" />
              <XRef ID="C0265344" DB="MedGen" />
              <XRef ID="MONDO:0009517" DB="MONDO" />
              <XRef Type="MIM" ID="246200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="36088" SubmissionDate="2016-12-05" DateLastUpdated="2017-01-06" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="147670.0028_DONOHUE SYNDROME" title="INSR, DEL_DONOHUE SYNDROME" />
        <ClinVarAccession Accession="SCV000036088" DateUpdated="2017-01-06" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1993-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Ardon et al. (2014) cataloged this mutation as a deletion of the entire INSR gene according to a revised INSR sequence (GenBank NC_000019).</Attribute>
              <Citation>
                <ID Source="PubMed">27896077</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 15-month-old boy with Donohue syndrome (246200), an offspring of first-cousin parents, Wertheimer et al. (1993) found homozygous deletion of the INSR gene. Thus, contrary to previous predictions, complete absence of the INSR gene is compatible with life.</Attribute>
              <Citation>
                <ID Source="PubMed">7693131</ID>
              </Citation>
              <XRef DB="OMIM" ID="246200" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="INSR" />
          </GeneList>
          <Name>INSR, DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="147670.0028" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DONOHUE SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="36088" TraitType="Disease" MappingType="Name" MappingValue="DONOHUE SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0265344" Name="Leprechaunism syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

